Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zhejiang Hisun Pharmaceutical Co. Ltd.

www.hisunpharm.com

Latest From Zhejiang Hisun Pharmaceutical Co. Ltd.

Deal Watch: Castle Creek Likes Partner Fibrocell Enough To Buy It

Dermatology-focused regenerative medicine firm Fibrocell has been reviewing strategic opportunities for more than a year; April’s FCX-007 license deal with Castle Creek results in buyout.

Deals Business Strategies

Hong Kong's PAG Acquires $540m Majority Stake In Hisun's Biosimilars Arm

Asia-focused PE firm PAG has purchased a majority stake in Hisun BioRay, the biotech division of Chinese state-owned generic company Zhejiang Hisun Pharmaceutical, for $540m, boosting its presence in a nascent, fast-growing segment of the country’s drug industry.

Deals Biosimilars

PE Interest In Hisun's Biosimilars Arm As Hong Kong Firm Acquires $540m Majority Stake

Asia-focused PE firm PAG has purchased a majority stake in Hisun BioRay, the biotech division of Chinese state-owned generic company Zhejiang Hisun Pharmaceutical, for $540m, boosting its presence in a nascent, fast-growing segment of the country’s drug industry.

China Business Strategies

Can Pharmas Come Out Unscathed As China-US Trade War Escalates?

As a simmering trade dispute between the US and China looks set to continue worsening, many companies in the pharma sector are closely watching what's coming and getting ready for any disruption. But what is the actual and predicted impact on exporters and producers in China, India and the US?

Trade China
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Zhejiang Hisun Pharmaceutical Co. Ltd.
  • Senior Management
  • Bai Hua, Pres. & CEO
  • Contact Info
  • Zhejiang Hisun Pharmaceutical Co. Ltd.
    Phone: (86) 4001180618
    46 Waisha Rd., Jiaojiang District
    Taizhou City,
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register